Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01967134
What this trial is testing

Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

Who this might be right for
Latent TuberculosisLatent Tuberculosis Bacteriology and Histology Unknown
Aeras 25
Early research (Phase 1)Study completedNCT00747734
What this trial is testing

MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 35
Early research (Phase 1)Ended earlyNCT03548064
What this trial is testing

Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area

Who this might be right for
Gastroenteritis Escherichia ColiImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 75
Early research (Phase 1)Study completedNCT00851734
What this trial is testing

A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)

Who this might be right for
Keratoconjunctivitis Sicca
Lux Biosciences, Inc. 35
Early research (Phase 1)Study completedNCT00138411
What this trial is testing

Monoclonal Antibody for Treatment of Inhalation Anthrax

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableLooking for participantsNCT06609265
What this trial is testing

Extracorporeal Shockwave Therapy (ESWT) for the Management of Stress Fractures and High-grade Bone Stress Injuries (BSIs)

Who this might be right for
Bones Stress InjuryBone Stress Fracture
University of California, Los Angeles 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT03162536
What this trial is testing

Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Who this might be right for
Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 190
Early research (Phase 1)Study completedNCT04052971
What this trial is testing

To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation

Who this might be right for
Advanced Solid Tumors
Abion Inc 24
Early research (Phase 1)Study completedNCT02991911
What this trial is testing

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
MedImmune LLC 33
Not applicableStudy completedNCT00002252
What this trial is testing

Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea

Who this might be right for
DiarrheaHIV Infections
Sandoz
Early research (Phase 1)Study completedNCT00825084
What this trial is testing

Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 45
Early research (Phase 1)Study completedNCT00697632
What this trial is testing

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 180
Early research (Phase 1)UnknownNCT00022906
What this trial is testing

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

Who this might be right for
Non-Hodgkin's Lymphoma
Corixa Corporation 24
Early research (Phase 1)Study completedNCT07202663
What this trial is testing

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

Who this might be right for
PharmacodynamicsPharmacokineticsHealthy Volunteers
Basking Biosciences, Inc. 72
Early research (Phase 1)Study completedNCT01298063
What this trial is testing

Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 35
Early research (Phase 1)Study completedNCT03486990
What this trial is testing

Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

Who this might be right for
Celiac Disease
Takeda 23
Early research (Phase 1)Study completedNCT03980080
What this trial is testing

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects

Who this might be right for
Healthy Subjects
OSE Immunotherapeutics 63
Early research (Phase 1)UnknownNCT03791125
What this trial is testing

Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets

Who this might be right for
Neuropathy of Diabetes
Peking University First Hospital 40
Early research (Phase 1)Study completedNCT04539340
What this trial is testing

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

Who this might be right for
Mucopolysaccharidosis Type IIMetabolic Diseases
AO GENERIUM 20
Testing effectiveness (Phase 2)Study completedNCT02280317
What this trial is testing

Dose Finding Safety Study of VAL201 in Cancer Patients

Who this might be right for
Stage III Prostate CarcinomaStage IV Prostate Carcinoma
ValiRx Plc 12
Next Page